office of innovation, partnerships and economic development

drug control - phase iii restrictions

clinical trials: phase iii restrictions


drugs disseminated during phase iii clinical trials, but after a preclinical submission has been filed, are subject to the following restrictions:

drug legislation

legislation


  • under construction. please check back after january 18, 2002.
  • controlled drugs and substances act (s.c. 1996, c. 19)
  • food and drug act
  • bill 159, personal health information privacy act, 2000. the government of ontario introduced draft legislation in december 2000, and is currently conducting province-wide consultations discussing acceptable collection, use, and disclosure of personal information in the health care sector.

pages

subscribe to office of innovation, partnerships and economic development